The Canadian Retinoblastoma Research Advisory Board (CRRAB) was created December 2016 and general membership includes people affected by retinoblastoma (e.g., survivors, the immediate family of someone diagnosed with retinoblastoma, etc.), clinicians, allied healthcare providers, researchers, patient engagement experts, and policymakers.
Establishing the Top 10 Retinoblastoma Research Priorities
From October to December 2017, we conducted a project to identify the top 10 retinoblastoma research priorities.
